See About page for reference for protein model. 1
Loading...

Shows odds (ROR or PRR) of reporting an adverse event (AE) and its statistical significance (adjusted p-value) for selected column. Points on the top right indicate increased risk for the AE in the context of the selected target. Points on the top left indicate decreased risk for the AE in the context of the selected target.


Significant Adverse Events

Includes AEs with adjusted p < 0.05 and |log2(ROR/PRR)| ≥ 1 in at least one facet.

About This Dashboard

This dashboard allows you to explore and visualize adverse event (AE) data related to GLP-1 RA therapies. Use the Visualizations tab to interact with the data.

Data Source

The data used in this dashboard is sourced from the FDA Adverse Event Reporting System (FAERS). We have processed and cleaned the data to provide meaningful insights into GLP-1 RA treatment related adverse events.

Reference
  1. Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes
    Zhang, Xin et al.
    Cell Reports, Volume 36, Issue 2, 109374
Download User Manual